THE MOIR MEDICAL CENTRE — All Prescriptions & Medications — Page 3
Practice Code: C81010 | NOTTINGHAM, NG10 1QQ
Showing results 101-150 of 637
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hyoscine butylbromide | 571 | 67.5K | £4.7K | +145.0% ▲ |
| Carbocisteine | 568 | 106.3K | £3.1K | +6.4% ▲ |
| 553 | 5,955 | £1.5K | +164.6% ▲ | |
| Sildenafil (Erectile Dysfunction) | 552 | 4,336 | £604 | +9.5% ▲ |
| Thiamine hydrochloride | 546 | 23.0K | £615 | +3.6% ▲ |
| Estradiol | 544 | 12.7K | £6.1K | +101.6% ▲ |
| Esomeprazole | 543 | 29.2K | £2.3K | +34.2% ▲ |
| 541 | 563 | £24.8K | +74.2% ▲ | |
| Other emollient preparations | 531 | 308.7K | £3.9K | -11.6% ▼ |
| Glyceryl trinitrate | 516 | 2,596 | £1.3K | +118.2% ▲ |
| Loperamide hydrochloride | 506 | 58.7K | £1.5K | +117.3% ▲ |
| Diclofenac diethyl | 506 | 68.8K | £3.3K | +42.5% ▲ |
| 501 | 8,118 | £4.0K | -24.6% ▼ | |
| Fluticasone propionate (Inhalation) | 499 | 697 | £14.9K | +29.0% ▲ |
| Olanzapine | 497 | 11.4K | £1.3K | +34.2% ▲ |
| Warfarin sodium | 487 | 59.0K | £2.3K | +3.3% ▲ |
| Sacubitril/valsartan | 472 | 28.3K | £46.2K | +97.1% ▲ |
| Sodium valproate | 472 | 72.8K | £8.0K | +48.4% ▲ |
| Buprenorphine | 469 | 2,837 | £6.4K | +28.0% ▲ |
| Mometasone furoate | 447 | 487 | £3.8K | +11.3% ▲ |
| Estriol | 445 | 7,692 | £4.4K | +109.1% ▲ |
| Irbesartan | 444 | 20.1K | £841 | +82.2% ▲ |
| Baclofen | 443 | 47.9K | £1.1K | +121.1% ▲ |
| Progesterone | 433 | 30.2K | £5.6K | +3.4% ▲ |
| Tiotropium bromide | 426 | 9,259 | £11.3K | +40.1% ▲ |
| Aripiprazole | 425 | 11.8K | £2.0K | +67.0% ▲ |
| Diltiazem hydrochloride | 405 | 23.1K | £4.4K | +31.9% ▲ |
| Melatonin | 404 | 22.8K | £4.7K | +21.5% ▲ |
| Carbamazepine | 396 | 38.4K | £2.9K | +33.4% ▲ |
| 396 | 188.7K | £1.5K | +334.3% ▲ | |
| Topiramate | 382 | 24.2K | £2.8K | +114.9% ▲ |
| Pravastatin sodium | 380 | 11.8K | £559 | +17.0% ▲ |
| Indapamide | 373 | 14.3K | £696 | -56.8% ▼ |
| 370 | 381 | £1.8K | +56.6% ▲ | |
| Trazodone hydrochloride | 353 | 23.5K | £1.2K | +72.7% ▲ |
| 349 | 51.0K | £1.6K | -26.4% ▼ | |
| Methotrexate | 342 | 11.6K | £684 | +5.1% ▲ |
| Cyclizine hydrochloride | 337 | 14.2K | £505 | +108.9% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 336 | 57.9K | £4.1K | +122.3% ▲ |
| Biphasic isophane insulin | 332 | 2,469 | £10.6K | +197.6% ▲ |
| Oxybutynin | 332 | 23.8K | £1.6K | +74.3% ▲ |
| Methylphenidate hydrochloride | 320 | 12.0K | £8.4K | +23.9% ▲ |
| Alogliptin | 319 | 12.2K | £11.0K | +25.8% ▲ |
| Quinine sulfate | 317 | 10.8K | £1.5K | +9.5% ▲ |
| Clobetasone butyrate | 316 | 14.7K | £1.6K | +54.8% ▲ |
| Betahistine hydrochloride | 309 | 33.6K | £1.2K | +29.4% ▲ |
| Prochlorperazine maleate | 309 | 13.1K | £795 | +52.9% ▲ |
| Ispaghula husk | 303 | 14.6K | £2.7K | +130.0% ▲ |
| Mirabegron | 301 | 10.5K | £9.7K | -25.1% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 300 | 312 | £13.8K | +79.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.